Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation

NCT07147452 is registered in ClinicalTrials.gov with Hospital del SAS de Jerez as lead sponsor.

NCT NCT07147452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07147452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation
Lead sponsor
Hospital del SAS de Jerez
Phase
Observational
Overall status
Active, not recruiting
Start date
August 1, 2017
Completion date
August 31, 2025
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer (gc), sentinel lymph node biopsy (slnb)